Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1005 participants.

Also called NCT02424383

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,005 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02424383
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02424383. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04-23 (actual); primary completion 2017-10-27 (actual). Results posted on 2020-05-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
Acronym
SAFE-DCB
Condition
Peripheral Arterial Disease
Condition
Peripheral Vascular Diseases
Condition
Arterial Occlusive Diseases
Intervention (Device)
PTA (Lutonix® 035 DCB Catheter)
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct02424383
Content hash
8b73baad1779ed992bab6eba751ac92b14bc612628f16d32b22c898db7e15485